Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H2AQ104 methyltransferase activity	FBLL1 FBL	5.31e-05	2	146	2	GO:1990259
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	PDGFRA MET KDR EPHA3 EPHA5	1.13e-04	65	146	5	GO:0004714
GeneOntologyMolecularFunction	protein-glutamine N-methyltransferase activity	FBLL1 FBL	1.59e-04	3	146	2	GO:0036009
GeneOntologyMolecularFunction	histone H2A methyltransferase activity	FBLL1 FBL	3.16e-04	4	146	2	GO:0140940
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	PDGFRA MET KDR EPHA3 EPHA5	4.00e-04	85	146	5	GO:0019199
GeneOntologyBiologicalProcess	regulation of cell adhesion	RAP1GAP ABI3BP DOCK8 MYO10 PKP4 AMBRA1 CAV1 DYSF CRKL ITPKB TAOK2 PKD1 SERPINE1 PKHD1 KIF14 KDR POLDIP2 MMP2 LYN MUC1 EPHA3 EPHA5	6.19e-07	927	146	22	GO:0030155
GeneOntologyBiologicalProcess	heart development	FAT4 ABI3BP PDGFRA PKD1L1 TXNRD2 SIRT1 CRKL MET TH ACAN PKD1 PDS5A KDR GNAQ MMP2 CPLANE1 EPHA3	2.65e-05	757	146	17	GO:0007507
GeneOntologyBiologicalProcess	regulation of GTPase activity	RAP1GAP DOCK8 PKP4 TBC1D25 CHN1 CRKL MET ARHGAP27 FGD6 EPHA3 EPHA5	2.74e-05	335	146	11	GO:0043087
GeneOntologyBiologicalProcess	protein autophosphorylation	SMG1 PDGFRA NEK10 CAV1 TAOK2 MET KDR LYN NLK	3.66e-05	228	146	9	GO:0046777
GeneOntologyBiologicalProcess	ephrin receptor signaling pathway	CHN1 MMP2 LYN EPHA3 EPHA5	3.97e-05	54	146	5	GO:0048013
GeneOntologyBiologicalProcess	cell chemotaxis	PDGFRA CORO1B DYSF CRKL MET HSD3B7 SERPINE1 KDR C5 MMP2 LYN	5.68e-05	363	146	11	GO:0060326
GeneOntologyBiologicalProcess	cell-cell adhesion	NPHS1 FAT4 CDH26 RAP1GAP PDGFRA DOCK8 MYO10 PKP4 PKD1L1 AMBRA1 GRID2 CAV1 ITPKB TAOK2 PKD1 PKHD1 DLG3 CTNND2 LYN EPHA3	7.38e-05	1077	146	20	GO:0098609
GeneOntologyBiologicalProcess	positive regulation of catalytic activity	ADCY4 RAP1GAP PDGFRA DOCK8 NEK10 PKP4 TBC1D25 CAV1 CHN1 SIRT1 CRKL TAOK2 MET FCRL3 KIF14 DLG3 KDR LYN EPHA5	1.21e-04	1028	146	19	GO:0043085
GeneOntologyBiologicalProcess	box C/D sno(s)RNA 3'-end processing	FBLL1 FBL	1.49e-04	3	146	2	GO:0000494
GeneOntologyBiologicalProcess	box C/D sno(s)RNA metabolic process	FBLL1 FBL	1.49e-04	3	146	2	GO:0033967
GeneOntologyBiologicalProcess	box C/D sno(s)RNA processing	FBLL1 FBL	1.49e-04	3	146	2	GO:0034963
GeneOntologyBiologicalProcess	regulation of hydrolase activity	RAP1GAP DOCK8 PKP4 TBC1D25 CAV1 CHN1 SIRT1 ITIH3 CRKL MET FCRL3 SERPINE1 ARHGAP27 LYN FGD6 EPHA3 EPHA5	1.63e-04	878	146	17	GO:0051336
GeneOntologyBiologicalProcess	cell-substrate adhesion	FNDC3B ABI3BP CRKL TAOK2 PKD1 SERPINE1 PKHD1 KIF14 KDR POLDIP2 EPHA3	1.66e-04	410	146	11	GO:0031589
GeneOntologyBiologicalProcess	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	ELL3 SIRT1 MUC1	1.82e-04	16	146	3	GO:1902166
GeneOntologyBiologicalProcess	cell junction assembly	NPHS1 CDH26 ABI3BP PKP4 FRMPD2 GRID2 CAV1 CSMD2 CRKL TAOK2 KDR POLDIP2 EPHA3	2.09e-04	569	146	13	GO:0034329
GeneOntologyCellularComponent	dendrite	ADCY4 RAP1GAP ABI3BP GRID2 TXNRD2 LMTK3 AR NGDN TAOK2 MET TH STRN4 SORCS2 DLG3 GNAQ CTNND2 EPHA3 EPHA5	2.84e-05	858	145	18	GO:0030425
GeneOntologyCellularComponent	dendritic tree	ADCY4 RAP1GAP ABI3BP GRID2 TXNRD2 LMTK3 AR NGDN TAOK2 MET TH STRN4 SORCS2 DLG3 GNAQ CTNND2 EPHA3 EPHA5	2.93e-05	860	145	18	GO:0097447
GeneOntologyCellularComponent	somatodendritic compartment	ADCY4 RAP1GAP ABI3BP MYO10 GRID2 TXNRD2 LMTK3 AR NGDN TAOK2 MET TH ACAN STRN4 SORCS2 DLG3 KDR GNAQ CTNND2 USH2A EPHA3 EPHA5	3.91e-05	1228	145	22	GO:0036477
GeneOntologyCellularComponent	membrane microdomain	NPC1 ASAH2 INPP5D HLA-F CAV1 DYSF PLPP2 KDR GNAQ LYN ASAH2B	4.85e-05	364	145	11	GO:0098857
GeneOntologyCellularComponent	membrane raft	NPC1 ASAH2 INPP5D HLA-F CAV1 PLPP2 KDR GNAQ LYN ASAH2B	2.23e-04	362	145	10	GO:0045121
GeneOntologyCellularComponent	transcription factor TFIIIC complex	GTF3C5 GTF3C3	7.04e-04	6	145	2	GO:0000127
GeneOntologyCellularComponent	adherens junction	CDH26 PKP4 AJM1 DLG3 CTNND2 LYN EPHA5	7.08e-04	212	145	7	GO:0005912
GeneOntologyCellularComponent	box C/D methylation guide snoRNP complex	FBLL1 FBL	9.81e-04	7	145	2	GO:0031428
GeneOntologyCellularComponent	box C/D RNP complex	FBLL1 FBL	9.81e-04	7	145	2	GO:0170049
GeneOntologyCellularComponent	caveola	ASAH2 CAV1 PLPP2 GNAQ ASAH2B	1.07e-03	111	145	5	GO:0005901
GeneOntologyCellularComponent	lamellipodium	ABI3BP DOCK8 MYO10 CORO1B DYSF ABLIM3 FGD6	1.14e-03	230	145	7	GO:0030027
MousePheno	abnormal innervation	GRID2 CHN1 AR MET ACAN SORCS2 DLG3 GNAQ EPHA5	3.46e-05	193	117	9	MP:0002184
MousePheno	abnormal nephron morphology	NPHS1 FAT4 SIRT1 MET HP PKD1 SERPINE1 PKHD1 PDS5A CPLANE1 LYN MGAT5B DNASE1	5.67e-05	426	117	13	MP:0003881
MousePheno	abnormal kidney physiology	NPHS1 FAT4 HSPA4L CAV1 SIRT1 MET HP PKD1 SERPINE1 PKHD1 LYN DNASE1	6.56e-05	372	117	12	MP:0002136
MousePheno	exocrine pancreas atrophy	SIRT1 PKD1	6.95e-05	2	117	2	MP:0009164
MousePheno	abnormal kidney cortex morphology	NPHS1 HSPA4L SIRT1 MET HP PKD1 SERPINE1 PKHD1 PDS5A LYN DNASE1	8.53e-05	324	117	11	MP:0000521
MousePheno	ocular hypotelorism	SIRT1 CRKL NOSIP	8.98e-05	11	117	3	MP:0006197
Domain	PROTEIN_KINASE_TYR	PDGFRA NEK10 LMTK3 MET KDR LYN EPHA3 EPHA5	7.09e-07	97	141	8	PS00109
Domain	Tyr_kinase_AS	PDGFRA NEK10 MET KDR LYN EPHA3 EPHA5	8.78e-06	97	141	7	IPR008266
Domain	PKD	PKD1L1 PKD1 SORCS2	1.44e-05	7	141	3	PF00801
Domain	PKD/Chitinase_dom	PKD1L1 PKD1 SORCS2	3.42e-05	9	141	3	IPR022409
Domain	PKD	PKD1L1 PKD1 SORCS2	3.42e-05	9	141	3	SM00089
Domain	Tyr_kinase_cat_dom	PDGFRA MET KDR LYN EPHA3 EPHA5	5.42e-05	88	141	6	IPR020635
Domain	TyrKc	PDGFRA MET KDR LYN EPHA3 EPHA5	5.42e-05	88	141	6	SM00219
Domain	Ceramidse_alk_C	ASAH2 ASAH2B	5.66e-05	2	141	2	PF17048
Domain	YccV-like	POLDIP2 FBXO21	5.66e-05	2	141	2	SM00992
Domain	YccV-like	POLDIP2 FBXO21	5.66e-05	2	141	2	PF08755
Domain	NEUT/ALK_ceramidase_C	ASAH2 ASAH2B	5.66e-05	2	141	2	IPR031331
Domain	Hemimethylated_DNA-bd_dom	POLDIP2 FBXO21	5.66e-05	2	141	2	IPR011722
Domain	Ceramidase_alk	ASAH2 ASAH2B	5.66e-05	2	141	2	IPR006823
Domain	PKD	PKD1L1 PKD1 SORCS2	6.65e-05	11	141	3	PS50093
Domain	PKD_dom	PKD1L1 PKD1 SORCS2	6.65e-05	11	141	3	IPR000601
Domain	-	PKD1L1 PKD1 SORCS2	6.65e-05	11	141	3	2.60.40.670
Domain	fn3	NPHS1 FNDC3B COL12A1 ABI3BP USH2A EPHA3 EPHA5	2.32e-04	162	141	7	PF00041
Domain	REJ	PKD1L1 PKD1	3.36e-04	4	141	2	PS51111
Domain	REJ_dom	PKD1L1 PKD1	3.36e-04	4	141	2	IPR014010
Domain	Pkinase_Tyr	PDGFRA MET KDR LYN EPHA3 EPHA5	4.42e-04	129	141	6	PF07714
Domain	-	NPHS1 FNDC3B COL12A1 ABI3BP PDGFRA HLA-F MET FCRL3 CEACAM21 PKHD1 KDR USH2A EPHA3 EPHA5	5.00e-04	663	141	14	2.60.40.10
Domain	FN3	NPHS1 FNDC3B COL12A1 ABI3BP USH2A EPHA3 EPHA5	5.17e-04	185	141	7	SM00060
Domain	Protein_kinase_ATP_BS	PDGFRA NEK10 SGK3 TAOK2 MET KDR LYN NLK EPHA3 EPHA5	6.16e-04	379	141	10	IPR017441
Domain	Ser-Thr/Tyr_kinase_cat_dom	PDGFRA MET KDR LYN EPHA3 EPHA5	6.32e-04	138	141	6	IPR001245
Domain	PROTEIN_KINASE_ATP	PDGFRA NEK10 LMTK3 SGK3 TAOK2 MET KDR LYN NLK EPHA3 EPHA5	7.34e-04	459	141	11	PS00107
Domain	FN3	NPHS1 FNDC3B COL12A1 ABI3BP USH2A EPHA3 EPHA5	7.96e-04	199	141	7	PS50853
Domain	PKD/REJ-like	PKD1L1 PKD1	8.32e-04	6	141	2	IPR002859
Domain	REJ	PKD1L1 PKD1	8.32e-04	6	141	2	PF02010
Domain	Ig-like_fold	NPHS1 FNDC3B COL12A1 ABI3BP PDGFRA HLA-F MET FCRL3 CEACAM21 PKHD1 KDR USH2A EPHA3 EPHA5	9.22e-04	706	141	14	IPR013783
Domain	FN3_dom	NPHS1 FNDC3B COL12A1 ABI3BP USH2A EPHA3 EPHA5	1.06e-03	209	141	7	IPR003961
Domain	Trimer_CC	CORO1B CORO6	1.16e-03	7	141	2	IPR015049
Domain	DUF1899	CORO1B CORO6	1.16e-03	7	141	2	IPR015048
Domain	Trimer_CC	CORO1B CORO6	1.16e-03	7	141	2	PF08954
Domain	DUF1899	CORO1B CORO6	1.16e-03	7	141	2	PF08953
Domain	Coronin	CORO1B CORO6	1.16e-03	7	141	2	IPR015505
Domain	Plakophilin/d_Catenin	PKP4 CTNND2	1.16e-03	7	141	2	IPR028435
Domain	DUF1899	CORO1B CORO6	1.16e-03	7	141	2	SM01166
Domain	PROTEIN_KINASE_DOM	PDGFRA NEK10 LMTK3 SGK3 TAOK2 MET KDR LYN NLK EPHA3 EPHA5	1.31e-03	493	141	11	PS50011
Domain	Tyr_kinase_rcpt_3_CS	PDGFRA KDR	1.54e-03	8	141	2	IPR001824
Domain	RECEPTOR_TYR_KIN_III	PDGFRA KDR	1.54e-03	8	141	2	PS00240
Pubmed	Neutral ceramidase secreted by endothelial cells is released in part associated with caveolin-1.	ASAH2 CAV1 ASAH2B	7.40e-08	3	147	3	12921776
Pubmed	PDZ-domain-directed basolateral targeting of the peripheral membrane protein FRMPD2 in epithelial cells.	PKP4 FRMPD2 CTNND2	2.95e-07	4	147	3	19706687
Pubmed	Localization of neutral ceramidase in caveolin-enriched light membranes of murine endothelial cells.	ASAH2 CAV1 ASAH2B	2.95e-07	4	147	3	11591392
Pubmed	Expression of ephrinA5 during development and potential involvement in the guidance of the mesostriatal pathway.	TH EPHA3 EPHA5	7.35e-07	5	147	3	19576892
Pubmed	CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.	INPP5D CRKL LYN	7.35e-07	5	147	3	11443118
Pubmed	The protein tyrosine kinase family of the human genome.	PDGFRA MET KDR LYN EPHA3 EPHA5	1.49e-06	83	147	6	11114734
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RPL27 FBL LSG1 PKP4 TMEM43 CORO1B CAV1 PRPF8 GTF3C5 GTF3C3 METTL14 FAM83B NOSIP NGDN SERPINE1 KIF14 LYN SPEN TOP2A	1.61e-06	1257	147	19	36526897
Pubmed	Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta.	MYO10 GRID2 CSMD2 TAOK2 TH POLDIP2	2.39e-06	90	147	6	15033168
Pubmed	c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.	CRKL MET LYN	2.56e-06	7	147	3	12244174
Pubmed	Identification of tyrosine kinases expressed in the male mouse gubernaculum during development.	PDGFRA MET KDR EPHA3	3.62e-06	25	147	4	15254900
Pubmed	A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase.	INPP5D GNAQ LYN	6.10e-06	9	147	3	10829070
Pubmed	SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways.	INPP5D CRKL LYN	8.69e-06	10	147	3	11157475
Pubmed	Murine txk: a protein tyrosine kinase gene regulated by T cell activation.	PDGFRA MET KDR LYN	1.00e-05	32	147	4	7542761
Pubmed	Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.	PDHA1 PDP1 PDP2	1.58e-05	12	147	3	12676647
Pubmed	Regulation of Microglial Signaling by Lyn and SHIP-1 in the Steady-State Adult Mouse Brain.	INPP5D LYN	1.77e-05	2	147	2	37830592
Pubmed	Genomic structure and promoter analysis of the mouse neutral ceramidase gene.	ASAH2 ASAH2B	1.77e-05	2	147	2	12435403
Pubmed	Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.	MET KDR	1.77e-05	2	147	2	30719715
Pubmed	Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage.	CAV1 MMP2	1.77e-05	2	147	2	22378877
Pubmed	SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.	SIRT1 MMP2	1.77e-05	2	147	2	23038275
Pubmed	A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease.	ASAH2 ASAH2B	1.77e-05	2	147	2	17334805
Pubmed	Functional analysis of Lyn kinase A and B isoforms reveals redundant and distinct roles in Fc epsilon RI-dependent mast cell activation.	INPP5D LYN	1.77e-05	2	147	2	20308635
Pubmed	The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab.	MET KDR	1.77e-05	2	147	2	33727583
Pubmed	Molecular cloning of the full-length cDNA encoding mouse neutral ceramidase. A novel but highly conserved gene family of neutral/alkaline ceramidases.	ASAH2 ASAH2B	1.77e-05	2	147	2	10753931
Pubmed	The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.	PKD1 PKHD1	1.77e-05	2	147	2	11919560
Pubmed	Regulation of the transcriptional activity of the tyrosine hydroxylase gene by androgen receptor.	AR TH	1.77e-05	2	147	2	16356647
Pubmed	MUC1 drives c-Met-dependent migration and scattering.	MET MUC1	1.77e-05	2	147	2	23193156
Pubmed	Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.	MET MUC1	1.77e-05	2	147	2	22962849
Pubmed	Androgen receptor promotes esophageal cancer cell migration and proliferation via matrix metalloproteinase 2.	AR MMP2	1.77e-05	2	147	2	25724186
Pubmed	Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.	MET MUC1	1.77e-05	2	147	2	16403482
Pubmed	Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease.	SIRT1 PKD1	1.77e-05	2	147	2	23778143
Pubmed	Anti-angiogenic and pro-apoptotic effects of a small-molecule JFD-WS in in vitro and breast cancer xenograft mouse models.	KDR MUC1	1.77e-05	2	147	2	29436685
Pubmed	The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy.	AR EPHA3	1.77e-05	2	147	2	30958616
Pubmed	Neutral ceramidase-dependent regulation of macrophage metabolism directs intestinal immune homeostasis and controls enteric infection.	ASAH2 ASAH2B	1.77e-05	2	147	2	35354041
Pubmed	A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes.	MET SERPINE1	1.77e-05	2	147	2	31054988
Pubmed	Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart.	CAV1 MMP2	1.77e-05	2	147	2	17349656
Pubmed	D-serine regulates cerebellar LTD and motor coordination through the δ2 glutamate receptor.	DAO GRID2	1.77e-05	2	147	2	21460832
Pubmed	Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury.	ASAH2 ASAH2B	1.77e-05	2	147	2	24659784
Pubmed	Oxidative stress-induced inhibition of Sirt1 by caveolin-1 promotes p53-dependent premature senescence and stimulates the secretion of interleukin 6 (IL-6).	CAV1 SIRT1	1.77e-05	2	147	2	25512378
Pubmed	Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.	AR NLK	1.77e-05	2	147	2	19514049
Pubmed	Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery.	MET MUC1	1.77e-05	2	147	2	14509156
Pubmed	Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression.	AR TOP2A	1.77e-05	2	147	2	26560244
Pubmed	Effects of SHIP-1 on MMP2 secretion and invasion of SR3Y1 cells.	INPP5D MMP2	1.77e-05	2	147	2	17498626
Pubmed	Caveolin-1 deficiency induces premature senescence with mitochondrial dysfunction.	CAV1 SIRT1	1.77e-05	2	147	2	28514055
Pubmed	Splicing Factor Prp8 Interacts With NES(AR) and Regulates Androgen Receptor in Prostate Cancer Cells.	PRPF8 AR	1.77e-05	2	147	2	26371515
Pubmed	Crystallization and preliminary crystallographic studies of the catalytic subunits of human pyruvate dehydrogenase phosphatase isoforms 1 and 2.	PDP1 PDP2	1.77e-05	2	147	2	20208177
Pubmed	Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury.	ASAH2 ASAH2B	1.77e-05	2	147	2	35151662
Pubmed	Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population.	ASAH2 ASAH2B	1.77e-05	2	147	2	37944753
Pubmed	A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.	MET KDR	1.77e-05	2	147	2	23548264
Pubmed	Role of neutral ceramidase in colon cancer.	ASAH2 ASAH2B	1.77e-05	2	147	2	27609772
Pubmed	Hypoxic stress disrupts HGF/Met signaling in human trophoblasts: implications for the pathogenesis of preeclampsia.	CAV1 MET	1.77e-05	2	147	2	35114998
Pubmed	Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney.	ASAH2 ASAH2B	1.77e-05	2	147	2	11328816
Pubmed	Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation.	ASAH2 ASAH2B	1.77e-05	2	147	2	19345744
Pubmed	Lactosylceramide contributes to mitochondrial dysfunction in diabetes.	ASAH2 ASAH2B	1.77e-05	2	147	2	26900161
Pubmed	Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death.	ASAH2 ASAH2B	1.77e-05	2	147	2	26747710
Pubmed	SIRT1 Deletion Impairs Retinal Endothelial Cell Migration Through Downregulation of VEGF-A/VEGFR-2 and MMP14.	SIRT1 KDR	1.77e-05	2	147	2	30452596
Pubmed	Impact of the loss of caveolin-1 on lung mass and cholesterol metabolism in mice with and without the lysosomal cholesterol transporter, Niemann-Pick type C1.	NPC1 CAV1	1.77e-05	2	147	2	24747682
Pubmed	Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.	ASAH2 ASAH2B	1.77e-05	2	147	2	16380386
Pubmed	Hormonal control of androgen receptor function through SIRT1.	AR SIRT1	1.77e-05	2	147	2	16923962
Pubmed	Identification and localization of a neurally expressed member of the plakoglobin/armadillo multigene family.	PKP4 CTNND2	1.77e-05	2	147	2	9342840
Pubmed	Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1.	INPP5D LYN	1.77e-05	2	147	2	20385881
Pubmed	Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling.	AR KDR	1.77e-05	2	147	2	23723256
Pubmed	Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized.	ASAH2 ASAH2B	1.77e-05	2	147	2	10652340
Pubmed	VEGF Receptor 2 (VEGFR2) Activation Is Essential for Osteocyte Survival Induced by Mechanotransduction.	CAV1 KDR	1.77e-05	2	147	2	25102966
Pubmed	Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.	CAV1 MET	1.77e-05	2	147	2	25148256
Pubmed	Neutral ceramidase gene: role in regulating ceramide-induced apoptosis.	ASAH2 ASAH2B	1.77e-05	2	147	2	14557071
Pubmed	Activation of SHIP by NADPH oxidase-stimulated Lyn leads to enhanced apoptosis in neutrophils.	INPP5D LYN	1.77e-05	2	147	2	11724799
Pubmed	Isoenzymes of pyruvate dehydrogenase phosphatase. DNA-derived amino acid sequences, expression, and regulation.	PDP1 PDP2	1.77e-05	2	147	2	9651365
Pubmed	Caveolin-1 expression predicts favourable outcome and correlates with PDGFRA mutations in gastrointestinal stromal tumours (GISTs).	PDGFRA CAV1	1.77e-05	2	147	2	34155091
Pubmed	Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu.	ASAH2 ASAH2B	1.77e-05	2	147	2	16126722
Pubmed	Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.	MET KDR	1.77e-05	2	147	2	27789775
Pubmed	Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.	ASAH2 ASAH2B	1.77e-05	2	147	2	22940715
Pubmed	Pathogenicity analysis of novel variations in Chinese Han patients with polycystic kidney disease.	PKD1 PKHD1	1.77e-05	2	147	2	28578020
Pubmed	Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA.	ASAH2 ASAH2B	1.77e-05	2	147	2	21613224
Pubmed	From AR to c-Met: androgen deprivation leads to a signaling pathway switch in prostate cancer cells.	AR MET	1.77e-05	2	147	2	23877345
Pubmed	The Niemann-Pick C1 and caveolin-1 proteins interact to modulate efflux of low density lipoprotein-derived cholesterol from late endocytic compartments.	NPC1 CAV1	1.77e-05	2	147	2	25285302
Pubmed	The oncometabolite d‑2‑hydroxyglutarate induces angiogenic activity through the vascular endothelial growth factor receptor 2 signaling pathway.	KDR MMP2	1.77e-05	2	147	2	30483760
Pubmed	Obesity induced caveolin-1 impairs osteogenesis via activating mitophagy and inhibiting Sirt1 signaling.	CAV1 SIRT1	1.77e-05	2	147	2	38844017
Pubmed	Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation.	CAV1 AR	1.77e-05	2	147	2	11278309
Pubmed	The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity.	INPP5D LYN	1.77e-05	2	147	2	12882960
Pubmed	METTL14 alleviates the development of osteoporosis in ovariectomized mice by upregulating m6A level of SIRT1 mRNA.	SIRT1 METTL14	1.77e-05	2	147	2	36584783
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	HSPA4L PKP4 LMTK3 ABLIM3 ATP8A1 AJM1 STRN4 CTNND2 NLK	1.82e-05	347	147	9	17114649
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	SMG1 FAT4 PDHA1 TBC1D25 CSMD2 GTF3C5 ITPKB NOSIP NGDN C5 CTNND2 SPEN	1.85e-05	638	147	12	31182584
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	FBLL1 VPS72 FBL CORO1B GTF3C5 GTF3C3 CRKL STRN4 KIF14 SPEN TOP2A	2.35e-05	549	147	11	38280479
Pubmed	Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.	PDGFRA MET EPHA3 EPHA5	2.49e-05	40	147	4	30898150
Pubmed	Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins.	COL12A1 SLC26A5 AMBRA1	2.60e-05	14	147	3	28511701
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPL27 ADCY4 PDHA1 HSPA4L FBL LSG1 VPS13C TMEM43 COLGALT1 PRPF8 GTF3C5 GTF3C3 CRKL KIF14 PDS5A POLDIP2 SPEN TOP2A	3.46e-05	1425	147	18	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RPL27 ADCY4 RAP1GAP PDHA1 HSPA4L DOCK8 PKP4 CORO1B ABLIM3 ITPKB ATP8A1 AJM1 STRN4 SORCS2 DLG3 CORO6 GNAQ CTNND2	3.65e-05	1431	147	18	37142655
Pubmed	Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells.	INPP5D CRKL LYN	3.98e-05	16	147	3	11071635
Pubmed	PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation.	RPL27 HSPA4L FBL PRPF8 GTF3C5 GTF3C3 POLDIP2	4.06e-05	217	147	7	31685992
Pubmed	Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein.	MAN2B2 COLGALT1 MGAT4C MGAT5B	4.35e-05	46	147	4	2649653
Pubmed	The transcription factor hepatocyte nuclear factor-6 controls the development of pancreatic ducts in the mouse.	PKD1 PKHD1 MUC1	4.82e-05	17	147	3	16472605
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	VPS13C HEATR5A SORCS2 PDP2 FGD6 CCDC191	4.98e-05	153	147	6	10718198
Pubmed	Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors.	PDGFRA KDR	5.31e-05	3	147	2	19779861
Pubmed	Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma.	PDGFRA MET	5.31e-05	3	147	2	25323095
Pubmed	PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.	PDGFRA KDR	5.31e-05	3	147	2	23146028
Pubmed	Balanced interactions between Lyn, the p85alpha regulatory subunit of class I(A) phosphatidylinositol-3-kinase, and SHIP are essential for mast cell growth and maturation.	INPP5D LYN	5.31e-05	3	147	2	21791602
Pubmed	Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.	CAV1 SERPINE1	5.31e-05	3	147	2	25337248
Pubmed	Identification of a functional hepatocyte nuclear factor 4 binding site in the neutral ceramidase promoter.	ASAH2 ASAH2B	5.31e-05	3	147	2	20803549
Pubmed	SIRT1 regulates tyrosine hydroxylase expression and differentiation of neuroblastoma cells via FOXO3a.	SIRT1 TH	5.31e-05	3	147	2	19285077
Pubmed	Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.	PDGFRA KDR	5.31e-05	3	147	2	21590454
Interaction	KIDINS220 interactions	PDGFRA PDHA1 CAV1 CRKL CEACAM21 KIF14 LYN EPHA3 EPHA5	9.12e-06	187	146	9	int:KIDINS220
Interaction	PTPN11 interactions	PDGFRA MRPL42 INPP5D CAV1 AR CRKL METTL14 NOSIP MET FCRL3 KDR EPHA5	1.58e-05	368	146	12	int:PTPN11
Interaction	FAM171A2 interactions	NSUN5P1 PDGFRA CAV1 MET LYN EPHA3 EPHA5	1.74e-05	112	146	7	int:FAM171A2
Interaction	DSG2 interactions	NPC1 PDGFRA PDHA1 CAV1 AR HSD3B7 KIF14 LYN EPHA3 EPHA5	1.79e-05	256	146	10	int:DSG2
Interaction	NSUN2 interactions	PDHA1 FBL LSG1 MRPL42 COLGALT1 LMTK3 PRPF8 AR METTL14 KIF14 KDR	2.42e-05	323	146	11	int:NSUN2
Interaction	SHB interactions	PDGFRA CAV1 AR MET KDR LYN	3.33e-05	84	146	6	int:SHB
Interaction	PIK3R1 interactions	PDGFRA INPP5D CAV1 PRPF8 AR SIRT1 CRKL MET GNAQ LYN EPHA3 EPHA5	4.75e-05	412	146	12	int:PIK3R1
Interaction	HSPD1 interactions	KCTD9 FNDC3B PDHA1 FBL MRPL42 USP25 AMBRA1 COLGALT1 PRPF8 AR SIRT1 CRKL METTL14 FLAD1 STRN4 KIF14 KDR HAGH POLDIP2 MGAT4C	4.92e-05	1022	146	20	int:HSPD1
Interaction	TNS2 interactions	KCTD9 CAV1 CRKL MET FLAD1 DZIP3 POLDIP2 FBXO21 MGAT5B	5.53e-05	235	146	9	int:TNS2
GeneFamily	Fibronectin type III domain containing	NPHS1 FNDC3B COL12A1 ABI3BP USH2A EPHA3 EPHA5	2.63e-05	160	98	7	555
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	PDGFRA LMTK3 MET KDR	6.39e-05	40	98	4	321
GeneFamily	WD repeat domain containing\|Coronins	CORO1B CORO6	6.00e-04	7	98	2	495
GeneFamily	Mannosyl-glycoprotein N-acetylglucosaminyltransferases	MGAT4C MGAT5B	1.02e-03	9	98	2	435
GeneFamily	SH2 domain containing	INPP5D CHN1 CRKL LYN	2.22e-03	101	98	4	741
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHA3 EPHA5	2.54e-03	14	98	2	1095
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 HP ACAN	3.66e-03	57	98	3	1179
GeneFamily	Protein phosphatases, Mg2+/Mn2+ dependent	PDP1 PDP2	3.75e-03	17	98	2	701
Coexpression	DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS	ADCY4 ASAH2 MYO1H CAV1 DYSF ITPKB TAOK2 SERPINE1 KDR ARHGAP27 ASAH2B	3.90e-07	272	146	11	MM3634
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	SMG1 DOCK8 MYO10 VPS13C PRPF8 ATP8A1 ZBTB40 KIF14	7.96e-06	180	146	8	M8239
Coexpression	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	PDGFRA KDR EPHA3 EPHA5	1.26e-05	26	146	4	M16488
Coexpression	GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP	FNDC3B HLA-F SIRT1 NGDN PDP1 PLCL2 ZBTB40 SPEN	1.71e-05	200	146	8	M4590
Coexpression	DODD_NASOPHARYNGEAL_CARCINOMA_UP	NPC1 SMG1 FNDC3B TCTN3 PDHA1 FBL MRPL42 PKP4 CAV1 COLGALT1 CHN1 GTF3C3 FAM83B C5orf34 ADO FLAD1 SERPINE1 KIF14 UNG FGD6 TOP2A	3.59e-05	1407	146	21	M14427
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	NPC1 DOCK8 VPS13C ATP8A1 ZBTB40 KIF14 PDP2 SPEN DOP1B	1.17e-08	185	147	9	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADCY4 DOCK8 INPP5D HLA-F DYSF CEACAM21 KDR ARHGAP27 LYN	1.22e-08	186	147	9	5d94e6dd2c92e0c46badeb1e6eb54b69af855a66
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	NPC1 DOCK8 VPS13C ATP8A1 ZBTB40 KIF14 PDP2 SPEN DOP1B	1.22e-08	186	147	9	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADCY4 DOCK8 INPP5D HLA-F DYSF CEACAM21 KDR ARHGAP27 LYN	1.22e-08	186	147	9	1da52e13096dfe4eb08bd0e7461cb3809b3b3deb
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 INPP5D CAV1 DYSF ITPKB SERPINE1 KDR RP1 LYN	1.28e-08	187	147	9	50d5730e2cd4951d3ad0641fc81ae9f6ddabafe7
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 INPP5D PKP4 CAV1 CHN1 DYSF ITPKB KDR CTNND2	1.69e-08	193	147	9	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 CAV1 DYSF ABLIM3 ITPKB KDR ARHGAP27	1.43e-07	178	147	8	ba2f0585626988b511046630bc16be5c5fec3fb2
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 INPP5D HLA-F DYSF ABLIM3 CEACAM21 KDR LYN	1.43e-07	178	147	8	4ef6344d0ffc9c55b1240bee94b741382f1427bb
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 INPP5D HLA-F DYSF ABLIM3 CEACAM21 KDR LYN	1.43e-07	178	147	8	c65932cbedbbfacb6f0299280663fe7c88dba72b
ToppCell	3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TCTN3 ADCY4 ISYNA1 CAV1 CHN1 DYSF ITIH3 KDR	1.49e-07	179	147	8	ec1d7017da325647b629de703135a404bbdc627d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RDH8 RAP1GAP NEK10 PKP4 FAM83B SORCS2 RP1 DNASE1	1.56e-07	180	147	8	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ADCY4 DOCK8 HLA-F DYSF ITIH3 KDR ARHGAP27 LYN	1.92e-07	185	147	8	3be9e05b929ac4d956b1d53284072f668a6c1959
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 DOCK8 INPP5D HLA-F DYSF CEACAM21 KDR LYN	1.92e-07	185	147	8	fb84fcf7f51f53489bcb3962fa9cb483e48257ed
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ADCY4 DOCK8 HLA-F DYSF ITIH3 KDR ARHGAP27 LYN	1.92e-07	185	147	8	c3dd64a726cb8a1fe048683c266b7532a714a52e
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 DOCK8 INPP5D HLA-F DYSF CEACAM21 KDR LYN	2.00e-07	186	147	8	9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-lymphatic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADCY4 INPP5D HLA-F CAV1 DYSF CEACAM21 KDR ARHGAP27	2.00e-07	186	147	8	86b218a400f9c64f92b050f00b49f09647b17437
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADCY4 INPP5D HLA-F CAV1 DYSF CEACAM21 KDR ARHGAP27	2.00e-07	186	147	8	f51c76b1c3c6c49e0ebc9a913d8413e0b6a04d80
ToppCell	facs-Trachea-nan-3m-Endothelial\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 ITPKB KDR	2.26e-07	189	147	8	f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	RDH8 MYO10 PKP4 AMBRA1 SORCS2 PKHD1 RP1 NLK	2.26e-07	189	147	8	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	facs-Trachea-nan-3m-Endothelial-endothelial_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 ITPKB KDR	2.26e-07	189	147	8	e3d65417997bdd3f9c312c0977dceb6eca061029
ToppCell	moderate-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FAT4 COL12A1 PDGFRA MYO10 CAV1 SERPINE1 KDR MMP2	2.26e-07	189	147	8	22a19365782003c18ec8dddcdbfdaa82c4e330f6
ToppCell	facs-Trachea-nan-3m-Endothelial-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 ITPKB KDR	2.26e-07	189	147	8	5559af03d9d612bb8dcf825e45744a9f8332bac8
ToppCell	facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 ITPKB KDR	2.36e-07	190	147	8	89d1d686cc683206534e2157554d7d0df5d53497
ToppCell	facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 ITPKB KDR	2.36e-07	190	147	8	65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640
ToppCell	facs-MAT-Fat-18m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR MGAT4C	2.36e-07	190	147	8	9aaa48f3aad813c87a45efdbb67d255c94f6e6a4
ToppCell	facs-MAT-Fat-18m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR MGAT4C	2.36e-07	190	147	8	34e56c5e7ea6a8f227dbaefe73cbb8818d18b523
ToppCell	facs-MAT-Fat-18m-Endothelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR MGAT4C	2.36e-07	190	147	8	14cdb660ad3aabcf49572173e7628d8b99dcbe6f
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADCY4 HSPA4L INPP5D PKP4 CHN1 DYSF KDR CTNND2	2.55e-07	192	147	8	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	facs-BAT-Fat-3m-Endothelial-nan\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 ITPKB KDR	2.66e-07	193	147	8	e340064cd146deac03f2d0fd43e2e218bb6057c9
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 INPP5D PKP4 CHN1 DYSF ITPKB KDR CTNND2	2.66e-07	193	147	8	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LARGE2 MET ATP8A1 PLPP2 PKHD1 RP1 CTNND2 MUC1	2.66e-07	193	147	8	aa10924b203c71e65fdbd2b90ba131dbd362d8b1
ToppCell	facs-BAT-Fat-3m-Endothelial-endothelial_cell\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 ITPKB KDR	2.66e-07	193	147	8	a211b386fd0fb9da9937361d29d90925a72c9715
ToppCell	facs-BAT-Fat-3m-Endothelial\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 ITPKB KDR	2.66e-07	193	147	8	3086c33f4d6fab66966818737f95ae4d6b2615b0
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	ADCY4 MYO10 PKP4 CAV1 ABLIM3 ITPKB KDR GNAQ	2.87e-07	195	147	8	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 INPP5D CAV1 DYSF CEACAM21 SERPINE1 KDR LYN	2.87e-07	195	147	8	ccfb80e3bfdf5304fa798e0a47b473955ecc0c6d
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADCY4 FAT4 COL12A1 PKP4 CAV1 TAOK2 KDR FGD6	3.48e-07	200	147	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	GRID2 CSMD2 CTNND2 USH2A MGAT4C EPHA3 EPHA5	1.01e-06	159	147	7	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CAV1 LMTK3 MET ATP8A1 ACAN SORCS2 RP1	1.59e-06	170	147	7	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	facs-Heart-RV-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 ABLIM3 ITPKB KDR	2.00e-06	176	147	7	3270a36fc91a5583646ffeb70bfcbc5af7292aac
ToppCell	facs-Heart-RV-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 ABLIM3 ITPKB KDR	2.00e-06	176	147	7	fb3d03f64592e1df1d9785d9f2e70938d7ff9ce8
ToppCell	facs-Heart-RV-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 ABLIM3 ITPKB KDR	2.00e-06	176	147	7	99410c121f55adbc7fcc013c8fa8905a45dba76b
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 CAV1 ABLIM3 ITPKB KDR ARHGAP27	2.15e-06	178	147	7	93ce73f8bcec63ebf86fabb546f88400e8f06465
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ADCY4 DOCK8 DYSF ITIH3 KDR ARHGAP27 LYN	2.23e-06	179	147	7	ab3d08b51cd7a37582305615ee221c7a2af83b40
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ADCY4 DOCK8 DYSF ITIH3 KDR ARHGAP27 LYN	2.23e-06	179	147	7	35fe9961e228ce255e3317fc244efa35b5adbf8b
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 CDH26 DYSF CEACAM21 KDR ARHGAP27 LYN	2.23e-06	179	147	7	abc6797bd3884aa75dca58fcb2523ee321243ab1
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 CDH26 DYSF CEACAM21 KDR ARHGAP27 LYN	2.23e-06	179	147	7	0b996d6e881f31e6b80d359f7caac70ecdeb9982
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RDH8 RAP1GAP PKP4 LMTK3 FAM83B SORCS2 RP1	2.50e-06	182	147	7	041bc819e6cf2618bf86bce8dfe2df673f392ba3
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	CDH26 ISYNA1 HSPA4L AR FAM83B MET PLPP2	2.59e-06	183	147	7	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LARGE2 PLEKHB1 PLPP2 PKHD1 RP1 CTNND2 MUC1	2.59e-06	183	147	7	c5b10571599dc26476170b54b53f09c23e6b3117
ToppCell	droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHS1 PDGFRA GALNT17 SERPINE1 KDR MMP2 MGAT5B	2.59e-06	183	147	7	f55081068213cc1cdb2acad58ff10f6b48b44c72
ToppCell	5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 CAV1 DYSF CEACAM21 SERPINE1 KDR ARHGAP27	2.68e-06	184	147	7	97e97de52daaff8840f4ee76a94ba5e3f79de7ce
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LARGE2 FRMPD2 PLEKHB1 CEACAM21 PKHD1 C5 CTNND2	2.68e-06	184	147	7	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	facs-Heart-RV\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 ABLIM3 ITPKB KDR	2.78e-06	185	147	7	7cf2b0db059605032bfae60cf1b93c4c62608f0c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RDH8 RAP1GAP NEK10 PKP4 SORCS2 RP1 DNASE1	2.78e-06	185	147	7	03f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCell	moderate-Lymphoid-NK\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FAT4 COL12A1 PDGFRA CAV1 SERPINE1 KDR MMP2	2.78e-06	185	147	7	4979a787acbc9b4ca8defe91cc79b674e51af1bf
ToppCell	droplet-Heart-nan-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 ARHGAP27	2.88e-06	186	147	7	49ad01d216860a2bd4d63905a7064471b02f2b37
ToppCell	Club_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	LARGE2 TCTN3 CAV1 SETDB1 ZBTB40 DNASE1	2.95e-06	120	147	6	7f85208f0455f3e634f8e7e81beea60b4ef1d2a5
ToppCell	facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 CAV1 DYSF ABLIM3 ITPKB KDR	3.09e-06	188	147	7	e5a8ca4613ab0bf1584b9e78959adf41d0bf379f
ToppCell	droplet-Fat-SCAT-30m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.09e-06	188	147	7	5cf060bb8adaefa9964187195d67993c1248ef47
ToppCell	facs-Heart-LV-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 CAV1 DYSF ABLIM3 ITPKB KDR	3.09e-06	188	147	7	0fc3a6562e6895f6fe7a93397eae842a75c60c93
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LARGE2 PLPP2 SORCS2 PKHD1 RP1 CTNND2 MUC1	3.09e-06	188	147	7	3cfba3addcc9058f4ec31ad96261f79988f551a0
ToppCell	droplet-Fat-SCAT-30m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.09e-06	188	147	7	e901a9bdf00b8e91806f445af66647373bf62661
ToppCell	facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 CAV1 DYSF ABLIM3 ITPKB KDR	3.09e-06	188	147	7	ed11e26ff4ef3d6314b5f5734062519b9aa285c1
ToppCell	droplet-Fat-Scat-21m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.09e-06	188	147	7	8671fdbc4138e6f9559920779c98628ed80f0da3
ToppCell	droplet-Heart-nan-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 ARHGAP27	3.09e-06	188	147	7	9dfa2e0b73640459cdf88277291e3ab9c33e0217
ToppCell	droplet-Fat-SCAT-30m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.09e-06	188	147	7	449f9602df3c83b2110eb479a00d428d1b55b423
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL12A1 ABI3BP PDGFRA TH ACAN SORCS2 MMP2	3.20e-06	189	147	7	40764f461b8aa1d3a2c5a30590b7fb9307d47d09
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL12A1 ABI3BP PDGFRA TH ACAN SORCS2 MMP2	3.20e-06	189	147	7	eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0
ToppCell	facs-GAT-Fat-24m-Endothelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.32e-06	190	147	7	da2fcd4a2cc6e45c8174109d892f1424e39919a1
ToppCell	droplet-Fat-Scat-21m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.32e-06	190	147	7	d3e46cf800a07ca9b01c78192962d223b9785d05
ToppCell	wk_08-11-Endothelial-Lymph_endothelial-Lymphatic_endo\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ADCY4 HLA-F DYSF ITIH3 KDR ARHGAP27 LYN	3.32e-06	190	147	7	279c5f68b993dc7adbf9aa69fffb1321cdebc48a
ToppCell	facs-GAT-Fat-24m-Endothelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.32e-06	190	147	7	3395b2ff6ffadf84cdb1b5a37a5b6be05b56c30f
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 CAV1 DYSF ABLIM3 ITPKB KDR	3.32e-06	190	147	7	38a815abf0ac5cac6071737cadc54a514f62d37d
ToppCell	droplet-Fat-Scat-21m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.32e-06	190	147	7	dd89ef1ecea20b2f6fbdc6cea4ca41b28b3ed822
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.32e-06	190	147	7	5174f91a880f85bb20806023aa68bd4b8ca24ea5
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 CAV1 DYSF ABLIM3 ITPKB KDR	3.32e-06	190	147	7	d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.32e-06	190	147	7	90e494cbfbed33a3a0d29bb7dae83f0c81580bcf
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.32e-06	190	147	7	c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073
ToppCell	facs-GAT-Fat-24m-Endothelial-endothelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.32e-06	190	147	7	e584eaccbc22aa7f7a4340ed8a2a8b45ddca93f4
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 CAV1 DYSF ABLIM3 ITPKB KDR	3.32e-06	190	147	7	bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e
ToppCell	wk_08-11-Endothelial-Lymph_endothelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ADCY4 HLA-F DYSF ITIH3 KDR ARHGAP27 LYN	3.32e-06	190	147	7	d7f1dc032d161529559e01832d1a3112c6f6cc1a
ToppCell	facs-SCAT-Fat-3m-Endothelial-endothelial_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.43e-06	191	147	7	6b9bbf4a63d4e9a8075bb06c2aa644fcf4ee88b8
ToppCell	facs-Heart-RV-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 ABLIM3 ITPKB KDR	3.43e-06	191	147	7	84ebb9f8e975acc88aa600c08a8aa791256948a6
ToppCell	facs-SCAT-Fat-3m-Endothelial-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.43e-06	191	147	7	a0018f88f7132477cc467ee15db029a585290595
ToppCell	facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 CAV1 DYSF ABLIM3 ITPKB KDR	3.43e-06	191	147	7	a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LARGE2 MET PLPP2 PKHD1 RP1 CTNND2 MUC1	3.43e-06	191	147	7	05731ece7867659c662f952812805f947032fe10
ToppCell	facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 CAV1 DYSF ABLIM3 ITPKB KDR	3.43e-06	191	147	7	827be47d3574c6c5b021c6f1c1670834344f10cb
ToppCell	facs-SCAT-Fat-3m-Endothelial\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.43e-06	191	147	7	90f0c193dce267a4f1a9b2501f636dafd0a34cf7
ToppCell	droplet-Fat-Gat-18m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.55e-06	192	147	7	df09056f0e562f53b6fb30b674d2d83e9eb857d0
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.55e-06	192	147	7	0986b7900021efe2a4df84a935e7c9a0af1b0e57
ToppCell	droplet-Fat-Gat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.55e-06	192	147	7	133b3ad251d72ff31e45e1dc6217945516ac63de
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Endothelial\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.55e-06	192	147	7	b28d294e42b303d1db6060231d84d7b9e4d9fccf
ToppCell	droplet-Fat-Gat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.55e-06	192	147	7	c312e39003c51503c9f648332fb5c6218f33f99b
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.55e-06	192	147	7	8f20d3511dcb44445592b17d005a53da0052ae56
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LARGE2 MET ATP8A1 PLPP2 PKHD1 RP1 CTNND2	3.55e-06	192	147	7	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	facs-MAT-Fat-24m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.68e-06	193	147	7	724bb613fa434add5b1c5586b629328f819fbdfe
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 PKP4 CAV1 CHN1 DYSF KDR CTNND2	3.68e-06	193	147	7	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 INPP5D DYSF ITPKB KDR GNAQ CTNND2	3.68e-06	193	147	7	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	FAT4 COL12A1 ABI3BP PDGFRA CHN1 GALNT17 MMP2	3.68e-06	193	147	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	facs-MAT-Fat-24m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 MYO10 PKP4 CAV1 DYSF ABLIM3 KDR	3.68e-06	193	147	7	737e540c72a3cfe8dbd4c0f139f7d729a166793a
Drug	U-19425	PDHA1 DAO PDP1 PDP2	1.11e-07	8	146	4	CID000009822
Drug	Phenylurea Compounds	PDGFRA AR KDR	1.03e-06	4	146	3	ctd:D010671
Drug	ponatinib	PDGFRA CRKL KDR LYN EPHA3 EPHA5	4.95e-06	68	146	6	ctd:C545373
Disease	melanoma (is_marker_for)	RAP1GAP CAV1 SETDB1 KDR PRAME	5.12e-07	33	142	5	DOID:1909 (is_marker_for)
Disease	Mood Disorders	DAO TBC1D25 AR SIRT1 TH HP DLG3 SMOX	1.64e-06	168	142	8	C0525045
Disease	atherosclerosis (biomarker_via_orthology)	CAV1 SIRT1 HP MMP2	2.35e-06	20	142	4	DOID:1936 (biomarker_via_orthology)
Disease	Malignant neoplasm of breast	FNDC3B RAP1GAP VPS72 FBL CAV1 FEM1C DYSF AR SIRT1 SGK3 C5orf34 FCRL3 HP KDR MMP2 SMOX SPEN TOP2A	4.33e-06	1074	142	18	C0006142
Disease	response to venlafaxine	COL12A1 CSMD2 DYSF ADO	6.01e-06	25	142	4	EFO_0006328
Disease	prostate cancer (is_marker_for)	CAV1 AR SIRT1 SETDB1 MMP2 MUC1 TOP2A	1.10e-05	156	142	7	DOID:10283 (is_marker_for)
Disease	Secondary Open Angle Glaucoma	FNDC3B CAV1 TXNRD2	2.33e-05	12	142	3	C0271148
Disease	Glaucoma, Open-Angle	FNDC3B CAV1 TXNRD2	2.33e-05	12	142	3	C0017612
Disease	Liver Cirrhosis, Experimental	ISYNA1 COL12A1 PDGFRA INPP5D DAO TMEM43 CAV1 DYSF ABLIM3 PLEKHB1 SIRT1 PLPP2 HAGH MMP2	2.36e-05	774	142	14	C0023893
Disease	Schizophrenia	DAO AMBRA1 CAV1 CSMD2 SIRT1 ITIH3 MET SETDB1 CEACAM21 HP PLCL2 DLG3 KDR HAGH CTNND2	2.46e-05	883	142	15	C0036341
Disease	cholangiocarcinoma (biomarker_via_orthology)	MET MMP2 MUC1	3.01e-05	13	142	3	DOID:4947 (biomarker_via_orthology)
Disease	Glaucoma, Primary Open Angle	FNDC3B CAV1 TXNRD2	3.01e-05	13	142	3	C0339573
Disease	Prostatic Neoplasms	PDHA1 CAV1 TXNRD2 AR SIRT1 MET SETDB1 PDP1 SERPINE1 PDS5A SPEN TOP2A	4.56e-05	616	142	12	C0033578
Disease	Malignant neoplasm of prostate	PDHA1 CAV1 TXNRD2 AR SIRT1 MET SETDB1 PDP1 SERPINE1 PDS5A SPEN TOP2A	4.56e-05	616	142	12	C0376358
Disease	high grade glioma (biomarker_via_orthology)	CAV1 MET MMP2	4.76e-05	15	142	3	DOID:3070 (biomarker_via_orthology)
Disease	endometriosis (biomarker_via_orthology)	KDR MMP2 LYN	5.84e-05	16	142	3	DOID:289 (biomarker_via_orthology)
Disease	Neuroblastoma	DOCK8 MET TH TOP2A	7.81e-05	47	142	4	C0027819
Disease	chronic obstructive pulmonary disease (is_marker_for)	HP SERPINE1 KDR C5 MUC1	1.09e-04	97	142	5	DOID:3083 (is_marker_for)
Disease	hypertension (biomarker_via_orthology)	PDGFRA CAV1 TH HP SERPINE1 KDR MMP2	1.20e-04	227	142	7	DOID:10763 (biomarker_via_orthology)
Disease	systemic scleroderma (is_marker_for)	CAV1 SERPINE1 KDR MUC1	1.25e-04	53	142	4	DOID:418 (is_marker_for)
Disease	pancreatic cancer (is_marker_for)	RAP1GAP PDGFRA MET MMP2 MUC1	1.31e-04	101	142	5	DOID:1793 (is_marker_for)
Disease	leukemia	AR HP PRAME TOP2A	1.45e-04	55	142	4	C0023418
Disease	urinary bladder cancer (is_marker_for)	CAV1 KDR MMP2 MUC1 TOP2A	1.72e-04	107	142	5	DOID:11054 (is_marker_for)
Disease	Major Depressive Disorder	ABI3BP TH HP SERPINE1 DLG3 KDR CTNND2	1.82e-04	243	142	7	C1269683
Disease	Malignant mesothelioma	COL12A1 MET SETDB1 MUC1 FGD6	1.88e-04	109	142	5	C0345967
Disease	Atherosclerosis	NPC1 SIRT1 HP SERPINE1	1.91e-04	59	142	4	C0004153
Disease	Atherogenesis	NPC1 SIRT1 HP SERPINE1	1.91e-04	59	142	4	C1563937
Disease	Glioblastoma Multiforme	PDGFRA MET MMP2 CTNND2 NLK	2.05e-04	111	142	5	C1621958
Disease	melanoma	FAT4 RAP1GAP PDGFRA MET SETDB1 GNAQ PRAME	2.07e-04	248	142	7	C0025202
Disease	acute kidney failure (biomarker_via_orthology)	AR SIRT1 MET HP	2.17e-04	61	142	4	DOID:3021 (biomarker_via_orthology)
Disease	sarcoma (is_marker_for)	MET KDR	2.28e-04	5	142	2	DOID:1115 (is_marker_for)
Disease	neurilemmoma (is_marker_for)	SERPINE1 KDR	2.28e-04	5	142	2	DOID:3192 (is_marker_for)
Disease	carcinoma (implicated_via_orthology)	FAT4 DLG3 KDR LYN	2.61e-04	64	142	4	DOID:305 (implicated_via_orthology)
Disease	adult respiratory distress syndrome (is_marker_for)	SERPINE1 C5 MUC1	2.62e-04	26	142	3	DOID:11394 (is_marker_for)
Disease	Depressive Symptoms	DAO TXNRD2 SERPINE1	2.62e-04	26	142	3	C0086132
Disease	Unipolar Depression	ABI3BP TH HP SERPINE1 DLG3 KDR CTNND2	2.69e-04	259	142	7	C0041696
Disease	non-alcoholic fatty liver disease (is_marker_for)	SIRT1 HP SERPINE1	2.93e-04	27	142	3	DOID:0080208 (is_marker_for)
Disease	Hypertensive disease	CAV1 AR TH HP SERPINE1 MMP2	3.26e-04	190	142	6	C0020538
Disease	Hyalinosis, Segmental Glomerular	NPHS1 SERPINE1 GNAQ	3.27e-04	28	142	3	C0086432
Disease	pyruvate decarboxylase deficiency (is_implicated_in)	PDHA1 PDP1	3.41e-04	6	142	2	DOID:3649 (is_implicated_in)
Disease	obstructive sleep apnea (is_marker_for)	HP SERPINE1 MUC1	3.64e-04	29	142	3	DOID:0050848 (is_marker_for)
Disease	asthma (is_marker_for)	HP SERPINE1 KDR C5 MUC1	3.68e-04	126	142	5	DOID:2841 (is_marker_for)
Disease	OROFACIODIGITAL SYNDROME VI	TCTN3 CPLANE1	4.75e-04	7	142	2	C2745997
Disease	retinal vein occlusion (is_implicated_in)	SERPINE1 MMP2	4.75e-04	7	142	2	DOID:1727 (is_implicated_in)
Disease	prostate cancer (implicated_via_orthology)	PRPF8 AR SIRT1	5.36e-04	33	142	3	DOID:10283 (implicated_via_orthology)
Disease	Glioblastoma	PDGFRA MET MMP2 CTNND2	5.84e-04	79	142	4	C0017636
Disease	Colorectal Carcinoma	FRMPD2 GRID2 CORO1B CINP PKHD1 DLG3 UNG KDR MMP2 CTNND2 EPHA3	6.10e-04	702	142	11	C0009402
Disease	bronchopulmonary dysplasia (is_marker_for)	SERPINE1 MUC1	6.32e-04	8	142	2	DOID:11650 (is_marker_for)
Disease	Focal glomerulosclerosis	NPHS1 SERPINE1 GNAQ	6.93e-04	36	142	3	C0017668
Disease	uveal melanoma (is_marker_for)	KDR PRAME	8.10e-04	9	142	2	DOID:6039 (is_marker_for)
Disease	abdominal aortic aneurysm (implicated_via_orthology)	SERPINE1 MMP2	8.10e-04	9	142	2	DOID:7693 (implicated_via_orthology)
Disease	dilated cardiomyopathy (is_marker_for)	IRF4 HP MMP2	8.78e-04	39	142	3	DOID:12930 (is_marker_for)
Disease	ductal carcinoma in situ (is_marker_for)	AR MMP2 TOP2A	8.78e-04	39	142	3	DOID:0060074 (is_marker_for)
Disease	sexual dimorphism measurement	NPC1 FNDC3B ADCY4 VPS72 UVSSA DYSF TAOK2 SETDB1 TH ADO ACAN PKD1 SMOX MUC1	9.30e-04	1106	142	14	EFO_0021796
Disease	invasive ductal carcinoma (is_marker_for)	AR CRKL MET	9.46e-04	40	142	3	DOID:3008 (is_marker_for)
Disease	prostate adenocarcinoma (is_marker_for)	PDGFRA KDR	1.01e-03	10	142	2	DOID:2526 (is_marker_for)
Disease	3-methyl-2-oxobutyrate measurement	FAT4 NLK	1.01e-03	10	142	2	EFO_0021020
Disease	middle cerebral artery infarction (biomarker_via_orthology)	IRF4 TH HP SERPINE1	1.08e-03	93	142	4	DOID:3525 (biomarker_via_orthology)
Disease	Multiple Myeloma	IRF4 MUC1 PRAME	1.09e-03	42	142	3	C0026764
Disease	high grade glioma (is_marker_for)	SETDB1 SERPINE1 KDR	1.09e-03	42	142	3	DOID:3070 (is_marker_for)
Disease	Autoimmune Diseases	FBL SIRT1 HP	1.09e-03	42	142	3	C0004364
Disease	systemic lupus erythematosus (implicated_via_orthology)	INPP5D LYN DNASE1	1.17e-03	43	142	3	DOID:9074 (implicated_via_orthology)
Disease	intracranial aneurysm (is_implicated_in)	PKD1 MMP2	1.47e-03	12	142	2	DOID:10941 (is_implicated_in)
Disease	focal segmental glomerulosclerosis (biomarker_via_orthology)	SERPINE1 MMP2	1.47e-03	12	142	2	DOID:1312 (biomarker_via_orthology)
Disease	Osteosarcoma	SIRT1 MET MMP2	1.52e-03	47	142	3	C0029463
Disease	Salivary Gland Neoplasms	ISYNA1 SPEN TOP2A	1.52e-03	47	142	3	C0036095
Disease	Weight Gain	MYO10 CAV1 MMP2 FBXO21	1.52e-03	102	142	4	C0043094
Disease	HIV Infections	PRPF8 SIRT1 HP LYN	1.57e-03	103	142	4	C0019693
Disease	HIV Coinfection	PRPF8 SIRT1 HP LYN	1.57e-03	103	142	4	C4505456
Disease	myeloid leukemia (is_implicated_in)	PDGFRA PRAME	1.73e-03	13	142	2	DOID:8692 (is_implicated_in)
Disease	congestive heart failure (biomarker_via_orthology)	TH HP ACAN MMP2	1.81e-03	107	142	4	DOID:6000 (biomarker_via_orthology)
Disease	Streptozotocin Diabetes	CAV1 SIRT1 SERPINE1 MMP2	1.87e-03	108	142	4	C0038433
Disease	Dupuytren Contracture	ADCY4 ACAN ZBTB40 KDR	1.87e-03	108	142	4	EFO_0004229
Disease	Diabetes Mellitus, Experimental	CAV1 SIRT1 SERPINE1 MMP2	1.87e-03	108	142	4	C0011853
Disease	Alloxan Diabetes	CAV1 SIRT1 SERPINE1 MMP2	1.87e-03	108	142	4	C0002152
Disease	pancreatic cancer (is_implicated_in)	PDGFRA KDR MUC1 EPHA3	2.14e-03	112	142	4	DOID:1793 (is_implicated_in)
Disease	open-angle glaucoma	FNDC3B CAV1 TXNRD2 SORCS2 PKHD1	2.36e-03	191	142	5	EFO_0004190
Disease	pneumonia (is_implicated_in)	SERPINE1 C5	2.64e-03	16	142	2	DOID:552 (is_implicated_in)
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	PKD1 PKHD1	2.64e-03	16	142	2	DOID:0110861 (implicated_via_orthology)
Disease	irritable bowel syndrome symptom measurement	HAGH CTNND2 DOP1B	2.77e-03	58	142	3	EFO_0021536
Disease	pre-eclampsia (is_marker_for)	HP SERPINE1 MMP2	2.77e-03	58	142	3	DOID:10591 (is_marker_for)
Disease	hypertension (is_implicated_in)	TH HP KDR MMP2	2.83e-03	121	142	4	DOID:10763 (is_implicated_in)
Disease	Hereditary Diffuse Gastric Cancer	FAT4 PDHA1 CAV1 MET SERPINE1 MUC1	3.02e-03	293	142	6	C1708349
Disease	pancreatic ductal carcinoma (is_marker_for)	MET MMP2 MUC1	3.20e-03	61	142	3	DOID:3587 (is_marker_for)
Disease	Stomach Neoplasms	FAT4 PDHA1 CAV1 MET SERPINE1 MUC1	3.23e-03	297	142	6	C0038356
Disease	Adenocarcinoma of lung (disorder)	FBL KDR TOP2A EPHA3 EPHA5	3.27e-03	206	142	5	C0152013
Disease	nevus count	DOCK8 IRF4	3.35e-03	18	142	2	EFO_0004632
Disease	Malignant neoplasm of stomach	FAT4 PDHA1 CAV1 MET SERPINE1 MUC1	3.39e-03	300	142	6	C0024623
Disease	renal cell carcinoma (is_marker_for)	PDGFRA CAV1 MMP2 MUC1	3.46e-03	128	142	4	DOID:4450 (is_marker_for)
Disease	transitional cell carcinoma (is_marker_for)	CAV1 KDR MMP2	3.51e-03	63	142	3	DOID:2671 (is_marker_for)
Disease	oral squamous cell carcinoma (is_marker_for)	MET HP SERPINE1	3.51e-03	63	142	3	DOID:0050866 (is_marker_for)
Disease	cholangiocarcinoma (is_marker_for)	MET MMP2 MUC1	3.67e-03	64	142	3	DOID:4947 (is_marker_for)
Disease	pulmonary hypertension (is_marker_for)	CAV1 HP SERPINE1	3.67e-03	64	142	3	DOID:6432 (is_marker_for)
Disease	Disorder of eye	TCTN3 PRPF8 RP1 CPLANE1 USH2A	3.69e-03	212	142	5	C0015397
Disease	osteoporosis (implicated_via_orthology)	AR SIRT1	3.73e-03	19	142	2	DOID:11476 (implicated_via_orthology)
Disease	susceptibility to cold sores measurement	GRID2 DYSF CTNND2	3.83e-03	65	142	3	EFO_0008402
Disease	obesity (implicated_via_orthology)	FAT4 AR SIRT1 HP GNAQ	3.92e-03	215	142	5	DOID:9970 (implicated_via_orthology)
Disease	breast carcinoma (is_marker_for)	PDGFRA CAV1 KDR	4.00e-03	66	142	3	DOID:3459 (is_marker_for)
Disease	keratoconus	FNDC3B COL12A1 PKHD1	4.00e-03	66	142	3	MONDO_0015486
Disease	myocardial infarction (implicated_via_orthology)	SERPINE1 KDR MMP2	4.00e-03	66	142	3	DOID:5844 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPDLHITPIYEGRTY	PKP4	406	Q99569
GFVAEERKHYTVYPP	UNG	116	P13051
VQRPDLISYEPHSRY	ABLIM3	321	O94929
PEDIPDYLLQYRAIH	ELL3	281	Q9HB65
EPNHDYIEIRNGPYE	CSMD2	2016	Q7Z408
HYYRVLEPVRPKEAS	ADO	221	Q96SZ5
LYFRPHEYNLDIPEG	ARHGEF37	301	A1IGU5
PFYRGNEDTPYEAVH	HSD3B7	141	Q9H2F3
HIPDTAQPGIYRIRY	ASAH2B	121	P0C7U1
AYVIDTHVRTPGPAY	CEACAM21	81	Q3KPI0
GVRTYIDPHTYEDPN	EPHA5	646	P54756
PRGSEAPVEYYIVSV	FAT4	1656	Q6V0I7
RENPYLIYDETDIPH	FAT4	4586	Q6V0I7
YGPRYVPEEPRAHST	AJM1	356	C9J069
SIRYFEITEEPPYIH	CORO1B	291	Q9BR76
HRDPYLRELGEPTYL	ADCY4	431	Q8NFM4
LPEYLPYAGIFHERG	AMBRA1	811	Q9C0C7
YVDSEGHLYTVPIRE	CAV1	6	Q03135
PEHHIDPIYEDRVYQ	CTNND2	416	Q9UQB3
PVKQGEEPDYETYLH	DDX25	416	Q9UHL0
HVAPLPDTYRGPYRE	PHYKPL	166	Q8IUZ5
IAGVAYGHVPEPEDY	ATP8A1	426	Q9Y2Q0
YRIIGYTPDLDPETV	MMP2	126	P08253
EDRVHYRSPPLATGY	RBM23	121	Q86U06
DIFRIYAPEAPYTSH	PDS5A	96	Q29RF7
DVAYHVVYREGPLYP	LARGE2	486	Q8N3Y3
PGRGEPRYIAVEYVD	HLA-F	36	P30511
SHLVDYFPEYDGPQR	GNAQ	286	P50148
YTPGEEPDHCVVIKY	ISYNA1	371	Q9NPH2
THDPERGIYNSPYII	DAO	216	P14920
PVVTPDGYLYEREAI	NOSIP	56	Q9Y314
ELEGRHIYIYVPDPD	PDGFRA	111	P16234
PGLDYVSHEDILPYT	POLDIP2	171	Q9Y2S7
RERILGPSHPDTSYY	FEM1C	326	Q96JP0
GTHYIPNAELEIRYP	FBXO21	591	O94952
VIHAPEEYYPILDGL	MGAT4C	171	Q9UBM8
FPGHLYDEVERTYPP	NPHS1	1171	O60500
VREHPVYGPYVEALS	KIF14	521	Q15058
SPEYFEPILNYLRHG	KCTD9	141	Q7L273
EYRQVPGSDPAHYEF	MAGEA9	256	P43362
PPEIAHGYVEHSVRY	HP	36	P00738
HRPPTSEELLTAYGY	LSG1	501	Q9H089
RGYDLPEHISNPEDY	IRF4	426	Q15306
LPPDTRVYCGHEYTI	HAGH	211	Q16775
LEPPLEEYYRETGIT	METTL14	191	Q9HCE5
HIPDTAQPGIYRIRY	ASAH2	736	Q9NR71
YYVELPDRTAHGAPD	DOP1B	1091	Q9Y3R5
YGQLDIFPARDTYHP	MUC1	1191	P15941
SEYYIRLEEHGSPPE	LMTK3	536	Q96Q04
RHSYAGEQPETVPYL	FAM83B	386	Q5T0W9
IHGTVYYESQRPPEV	MGAT5B	491	Q3V5L5
DYTLSVRPPVYLHDV	GRID2	141	O43424
LEPYERDHAVVVGVY	FBLL1	311	A6NHQ2
IVEAVYEPVPEGIYS	NEK10	741	Q6ZWH5
RYTPAYAHLVTPAEE	PEX5	431	P50542
PYERDHAVVVGVYRP	FBL	301	P22087
DYTLHAAIPPLEEVY	MYO10	1841	Q9HD67
ETARDHVLPIDYYFP	AR	541	P10275
LAVSPLDPRYREVHY	NSUN5P1	21	Q3KNT7
PPHIDYFEEIYVVTE	NLK	206	Q9UBE8
DSIRYPYRPDTITHG	PLPP2	41	O43688
HYLDTTTLIEPAPRY	CRKL	91	P46109
GPYDDVRISPVIYHF	CYHR1	306	Q6ZMK1
TPPYLTAEPEVTYHR	PDP1	391	Q9P0J1
DYHQLSVYLGIPVPE	DZIP3	561	Q86Y13
HYRPGPTRYSLTFEE	ACAN	481	P16112
PGTDPETLHYFRDLY	RDH8	206	Q9NYR8
QYLHAGPPVYFVLEE	NPC1	881	O15118
APELVIYEDSERYPG	IGLV3-22	61	A0A075B6J6
PPYLTAEPEVTYHRL	PDP2	386	Q9P2J9
IDSAGPLYYVHVEPT	HEATR5A	961	Q86XA9
EFPTREVYVPHTVYR	DOCK8	546	Q8NF50
YPEDVRVPLRDKYHS	CPLANE1	1371	Q9H799
RIIYSPTVGDPIDEY	COL12A1	2056	Q99715
APDTYHYVVSEPLGR	DNASE1	81	P24855
PYFHVEDYIPASLIE	FRMPD2	491	Q68DX3
LPHTIYGEQEIIPFY	FNDC3B	161	Q53EP0
EYVLPHFSVSIEPEY	C5	221	P01031
VVEYYSHRGLPPRSL	CPNE7	606	Q9UBL6
ILPDFQVPGRYHELY	CCDC191	906	Q8NCU4
EVVHRYYRPDLTIPE	BRAWNIN	26	Q69YU5
VPLEEYVHKRYPGLV	GALNT17	201	Q6IS24
IRYFEITDEPPFVHY	CORO6	291	Q6QEF8
YEPVTRQEIHYARPV	DLG3	616	Q92796
PGLRTYVDPHTYEDP	EPHA3	591	P29320
SCLGEHEVPVPSYYR	HOXC10	136	Q9NYD6
PPILYRFYHEDVTLG	FCRL3	411	Q96P31
RLYHLYEVGEDPVLS	MAN2B2	916	Q9Y2E5
DIVVALYPYDGIHPD	LYN	66	P07948
NVLEDDPGYLPHVYS	CDH26	771	Q8IXH8
PIYEHVGYTTLNREP	CHN1	141	P15882
VEPLLIYPTHYTGDD	COLGALT1	551	Q8NBJ5
GHPTYRPAYLLENEE	FLAD1	566	Q8NFF5
LIQIEHPEPYERYVT	C5orf34	516	Q96MH7
RPYSHALVAGIDRYP	RPL27	36	P61353
LVRYPELYNHPDVRA	SGK3	101	Q96BR1
PPSIVVELYDHDTYG	DYSF	1221	O75923
TEVELGPYYVEIGHE	PKD1L1	426	Q8TDX9
YTLLDGHYLSEEPEP	PKD1	2926	P98161
FTTPDGHYYDILELP	SERPINE1	236	P05121
HTYEGACPIDETYVP	RP1	1321	P56715
FSYREDPIVYEIHPT	MET	736	P08581
SHYRVVYQERPDDPT	USH2A	3996	O75445
YHSENPKYPEVGDLR	TMEM43	226	Q9BTV4
RARAPVVPYGVDLHY	UVSSA	496	Q2YD98
HPEVYRVLFDYQPEA	SH3D21	66	A4FU49
LTHVLYPVPLESYED	PRAME	436	P78395
YPVPLESYEDIHGTL	PRAME	441	P78395
DVLRTDRAHPYYAGP	TBC1D25	291	Q3MII6
VHFGRDEEDPTYDYP	TMEM132E	811	Q6IEE7
YYVERPIFSHPVLQE	SLC26A5	16	P58743
YYVDGDPHFIIQIPE	ITIH3	646	Q06033
DVLRPFVPAYHGDVV	ITPKB	706	P27987
GDVVDPYVYVEIHGI	PLCL2	776	Q9UPR0
PYVYVEIHGIPADCA	PLCL2	781	Q9UPR0
GPPITEAYVTDVLYR	SMG1	421	Q96Q15
VGDVYVLVEHPFEYT	ARHGAP27	6	Q6ZUM4
EPIRHRYESPGIYRV	SORCS2	836	Q96PQ0
DYIPYPSVHEVLGRE	RAP1GAP	26	P47736
YIPHDIYVIGTQEDP	INPP5D	441	Q92835
PPNRYIFHGAEVYSD	SIRT1	646	Q96EB6
IHRLPGSDNLYDDPY	TAOK2	416	Q9UL54
VPSLPAGEYHVRGYD	PKHD1	1706	P08F94
YHPPADKLYVGSRVV	SETDB1	251	Q15047
YVQAFRTHPDEPLYS	GTF3C3	756	Q9Y5Q9
ELENYHYGEESKRPP	CINP	121	Q9BW66
LYSHLVPVYDVEPLE	PRPF8	901	Q6P2Q9
YLTVEGHIYPTVDRE	RPA4	241	Q13156
QSEYRLHPYTVPRDV	SPEN	3181	Q96T58
LEELGYHIYSSDPPF	PDHA1	361	P08559
YHIYSSDPPFEVRGA	PDHA1	366	P08559
YVPPRLVPVHYDETE	NGDN	171	Q8NEJ9
YTNLHEVPYPDARIG	HSPA4L	446	O95757
YEVVPPNAHEATYVR	PLEKHB1	176	Q9UF11
RTIVCYHPSVDIPYE	MRPL42	56	Q9Y6G3
IRHYEEIPEYENLPF	FGD6	751	Q6ZV73
FDVLYPPERYGHVLS	SMOX	411	Q9NWM0
TPPETDYRLHHVVVY	USP25	796	Q9UHP3
LYRTVIQPGIYHPDI	VPS13C	1301	Q709C8
PPLITDYREYHTDTT	TOP2A	951	P11388
VDVHPSVYTGEKPYL	ZNF41	356	P51814
RPRYPTHIEGALEYG	TXNRD2	191	Q9NNW7
DPYDGYDPSVLSHVL	STRN4	526	Q9NRL3
LDAPVDYFYRPETQH	GTF3C5	176	Q9Y5Q8
YRIYDVVLSPSHGIE	KDR	221	P35968
HRPALYRDPVTDIPY	VPS72	296	Q15906
HFESYEYSLAPPRGV	ZC3H10	221	Q96K80
IYQTLHGRPRPEYVA	TCTN3	446	Q6NUS6
YDQDHTVPAYVPRKL	ABI3BP	226	Q7Z7G0
YIHRTPREGYDPSTL	ZNF76	71	P36508
PSPDDYGTELLRRYH	ZBTB40	456	Q9NUA8
AFQYRHGDPIPRVEY	TH	241	P07101
ELPPHVYAIADNAYR	MYO1H	76	Q8N1T3